{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:09:57Z","timestamp":1778429397397,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["10250022110002"],"award-info":[{"award-number":["10250022110002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nbd.2026.107296","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:26:41Z","timestamp":1769707601000},"page":"107296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impedance-based phenotypic profiling of metabotropic glutamate receptor ligand responses in SCA1 human iPSC-derived neuronal cultures"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-8189","authenticated-orcid":false,"given":"Laurie M.C.","family":"Kerkhof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-8110","authenticated-orcid":false,"given":"Ronald A.M.","family":"Buijsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8154-984X","authenticated-orcid":false,"given":"Barry A.","family":"Pepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-5376","authenticated-orcid":false,"given":"Linda M.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-4511","authenticated-orcid":false,"given":"Jean-Philippe","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0136-8811","authenticated-orcid":false,"given":"Rongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-8464","authenticated-orcid":false,"given":"Laura H.","family":"Heitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3035-0533","authenticated-orcid":false,"given":"Willeke M.C.","family":"van Roon-Mom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2026.107296_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","article-title":"Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer\u2019s disease and dementia with Lewy bodies correlates with stage of Alzheimer\u2019s-disease-related changes","volume":"20","author":"Albasanz","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"30","key":"10.1016\/j.nbd.2026.107296_bb0010","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1523\/JNEUROSCI.0876-14.2014","article-title":"Mutant \u03b2-III spectrin causes mGluR1\u03b1 mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5","volume":"34","author":"Armbrust","year":"2014","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2026.107296_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng0894-513","article-title":"Identification and characterization of the gene causing type 1 spinocerebellar ataxia","volume":"7","author":"Banfi","year":"1994","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.nbd.2026.107296_bb0020","doi-asserted-by":"crossref","first-page":"E2725","DOI":"10.1073\/pnas.1504393112","article-title":"Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro","volume":"112","author":"Bardy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107296_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.scr.2018.03.018","article-title":"Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and B","volume":"29","author":"Buijsen","year":"2018","journal-title":"Stem Cell Res."},{"issue":"8","key":"10.1016\/j.nbd.2026.107296_bb0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.29446","article-title":"Spinocerebellar Ataxia type 1 characteristics in patient-derived fibroblast and iPSC-derived neuronal cultures","volume":"38","author":"Buijsen","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0035","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1038\/s41467-021-25620-5","article-title":"Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.nbd.2026.107296_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1087057114563025","article-title":"Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line","volume":"20","author":"Chen","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.nbd.2026.107296_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.mcb.2018.08.003","article-title":"Label-free impedance-based whole cell assay to study GPCR pharmacology","volume":"149","author":"Doornbos","year":"2019","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.nbd.2026.107296_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2018.03.026","article-title":"Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor","volume":"152","author":"Doornbos","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.nbd.2026.107296_bb0060","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2016.03.044","article-title":"Re-exploration of the mGlu\u2081 PAM Ro 07-11401 scaffold: discovery of analogs with improved CNS penetration despite steep SAR","volume":"26","author":"Garcia-Barrantes","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.nbd.2026.107296_bb0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0896-6273(03)00769-4","article-title":"RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways","volume":"40","author":"Gold","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107296_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coph.2016.10.007","article-title":"Neurobiological insights and novel therapeutic opportunities for CNS disorders from mGlu receptor allosteric and biased modulation","volume":"32","author":"Hellyer","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107296_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050788","article-title":"Therapeutic strategies for spinocerebellar Ataxia type 1","volume":"13","author":"Kerkhof","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2026.107296_bb0080","series-title":"Generation of an Isogenic Human Induced Pluripotent Stem Cell Line for Spinocerebellar ataxia Type 1","author":"Kerkhof","year":"2026"},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12311-013-0516-5","article-title":"Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells","volume":"13","author":"Konno","year":"2014","journal-title":"Cerebellum"},{"issue":"5","key":"10.1016\/j.nbd.2026.107296_bb0100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2003.11.014","article-title":"Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using [3H]R214127","volume":"46","author":"Lavreysen","year":"2004","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.nbd.2026.107296_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233916","article-title":"Targeting mGlu1 receptors in the treatment of motor and cognitive dysfunctions in mice modeling type 1 spinocerebellar Ataxia","volume":"11","author":"Liberatore","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.nbd.2026.107296_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72101","article-title":"Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1","volume":"3","author":"Lin","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107296_bb0120","article-title":"Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation","author":"Lopez-Balastegui","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.nbd.2026.107296_bb0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/cercor\/12.6.625","article-title":"Differential distribution of group I metabotropic glutamate receptors during rat cortical development","volume":"12","author":"L\u00f3pez-Bendito","year":"2002","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2026.107296_bb0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.98031.3","article-title":"Astrocytes mediate two forms of spike timing-dependent depression at entorhinal cortex-hippocampal synapses","volume":"13","author":"Mart\u00ednez-Gallego","year":"2024","journal-title":"Elife"},{"issue":"Pt 7","key":"10.1016\/j.nbd.2026.107296_bb0135","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/brain\/awr137","article-title":"Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys","volume":"134","author":"Masilamoni","year":"2011","journal-title":"Brain"},{"issue":"Pt 13","key":"10.1016\/j.nbd.2026.107296_bb0140","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1113\/jphysiol.2011.207563","article-title":"Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice","volume":"589","author":"Mitsumura","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107296_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109569","article-title":"GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders","volume":"235","author":"Nicoletti","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2026.107296_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1756-6606-6-48","article-title":"Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1","volume":"6","author":"Notartomaso","year":"2013","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0155","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1038\/s41598-018-31369-7","article-title":"mGlu1 receptors monopolize the synaptic control of cerebellar Purkinje cells by epigenetically down-regulating mGlu5 receptors","volume":"8","author":"Notartomaso","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107296_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113791","article-title":"Therapeutic potential of d-cysteine against in vitro and in vivo models of spinocerebellar ataxia","volume":"343","author":"Ohta","year":"2021","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.nbd.2026.107296_bb0165","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.neuron.2023.05.016","article-title":"Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1","volume":"111","author":"Pilotto","year":"2023","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.nbd.2026.107296_bb0170","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1523\/JNEUROSCI.3953-15.2016","article-title":"Prolonged type 1 metabotropic glutamate receptor dependent synaptic signaling contributes to spino-cerebellar Ataxia type 1","volume":"36","author":"Power","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuron.2015.11.033","article-title":"Impaired mTORC1-dependent expression of Homer-3 influences SCA1 pathophysiology","volume":"89","author":"Ruegsegger","year":"2016","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.nbd.2026.107296_bb0180","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/hmg\/ddh268","article-title":"Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice","volume":"13","author":"Serra","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2026.107296_bb0185","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2006.09.036","article-title":"RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice","volume":"127","author":"Serra","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.nbd.2026.107296_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2008.04.021","article-title":"Metabotropic glutamate receptors (mGlus) and cellular transformation","volume":"55","author":"Shin","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/JP272950","article-title":"Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice","volume":"595","author":"Shuvaev","year":"2017","journal-title":"J. Physiol."},{"issue":"14","key":"10.1016\/j.nbd.2026.107296_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142247","article-title":"Indirect negative effect of mutant Ataxin-1 on short- and long-term synaptic plasticity in mouse models of spinocerebellar Ataxia type 1","volume":"11","author":"Shuvaev","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.nbd.2026.107296_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029420","article-title":"Impedance responses reveal \u03b2\u2082-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles","volume":"7","author":"Stallaert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107296_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neures.2022.03.001","article-title":"Amyloid-\u03b2 oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: relevance to the synapse pathology of Alzheimer\u2019s disease","volume":"180","author":"Taniguchi","year":"2022","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.nbd.2026.107296_bb0215","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1152\/jn.01101.2007","article-title":"Homer 1a suppresses neocortex long-term depression in a cortical layer-specific manner","volume":"99","author":"Ueta","year":"2008","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107296_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajhg.2017.08.005","article-title":"Dominant mutations in GRM1 cause spinocerebellar Ataxia type 44","volume":"101","author":"Watson","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"40","key":"10.1016\/j.nbd.2026.107296_bb0225","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","article-title":"Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice","volume":"24","author":"Zu","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:59:23Z","timestamp":1778018363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0969996126000409"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107296","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impedance-based phenotypic profiling of metabotropic glutamate receptor ligand responses in SCA1 human iPSC-derived neuronal cultures","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107296"}}